Array
(
[id] => 5614397
[patent_doc_number] => 20060116325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => 'Methods and compositions for inhibiting hiv-coreceptor interactions'
[patent_app_type] => utility
[patent_app_number] => 10/468182
[patent_app_country] => US
[patent_app_date] => 2002-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 31014
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20060116325.pdf
[firstpage_image] =>[orig_patent_app_number] => 10468182
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/468182 | Methods and compositions for inhibiting hiv-coreceptor interactions | Feb 14, 2002 | Abandoned |
Array
(
[id] => 7750785
[patent_doc_number] => 08110204
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-07
[patent_title] => 'Method of treating human-immunodeficiency virus (HIV) disease infection'
[patent_app_type] => utility
[patent_app_number] => 10/468467
[patent_app_country] => US
[patent_app_date] => 2002-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7712
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/110/08110204.pdf
[firstpage_image] =>[orig_patent_app_number] => 10468467
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/468467 | Method of treating human-immunodeficiency virus (HIV) disease infection | Jan 16, 2002 | Issued |
Array
(
[id] => 6692200
[patent_doc_number] => 20030039632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-27
[patent_title] => 'Novel bacteriocins, transport and vector system and method of use thereof'
[patent_app_type] => new
[patent_app_number] => 09/883343
[patent_app_country] => US
[patent_app_date] => 2001-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 30552
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20030039632.pdf
[firstpage_image] =>[orig_patent_app_number] => 09883343
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/883343 | Novel bacteriocins, transport and vector system and method of use thereof | Jun 18, 2001 | Abandoned |
Array
(
[id] => 432044
[patent_doc_number] => 07264817
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-09-04
[patent_title] => 'Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it'
[patent_app_type] => utility
[patent_app_number] => 08/459141
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 17
[patent_no_of_words] => 17068
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/264/07264817.pdf
[firstpage_image] =>[orig_patent_app_number] => 08459141
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/459141 | Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it | Jun 1, 1995 | Issued |